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tations in coronary blood flow. The "blood doping" effect may provide a phys-
iological explanation for the use of COC by athletes.
KATP channel blockade combined with adenosine receptor blockade de-
creased coronary blood flow, but did not block the increase in coronary blood
flow in response to exercise. However, the subsequent addition of LNNA did
block exercise-induced coronary vasodilation. Thus, when other vasodilator
mechanisms are inhibited, endothelial production of NO can be shown to
contribute to vasodilation of coronary resistance vessels during exercise.
Heart Rate (beats/minl CBF (mllminl CVC(xl0-2ml!min/mmHg)
Con G+PT G+PT+L Can G+PT G+PT+L Can G+PT G+PT+L
Rest 119±5 139±6# 134±10# 51± 4 29±3# 21±3#t 59±5 32±4# 27±2#t
Ex 1 191±5* 195±5* lSS± 5* 77± S* 37±5# 24±4#t 91±10* 43±6# 29±6#t
Ex 2 225±7* 219±7* 211± S* 91±10* 49±6*# 32±5#t 113±12* 5S±7*# 34±5#t
*P < 0.05 vs Rest, #p < 0.05 vs Can, t p < 0.05 vs G+PT: CVC ~ coronary vascular
conductance
Nitrate Tolerance: Impaired Vascular Effects of
Stimulation and Inhibition of Nitric Oxide
Release in Vivo
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Atherosclerosis impairs endothelium-mediated relaxation (EMR) in the hu-
man coronary artery. Endothelial xanthine oxidase (XO) generates superoxide
anion, an inactivator of nitric oxide. In the hypercholesterolemic rabbit aorta,
endothelial XO-induced superoxide anion production is reduced by oxypuri-
nol, restoring normal EMR. We hypothesized that XO inhibition with allop-
urinol would improve coronary EMR in patients with atherosclerosis. To as-
sess the effects of XO inhibition on EM R, we studied 18 patients (risk factors
+ mild atherosclerosis) with serial intracoronary infusions of acetylcholine
IACH) (10-S to 10-6M) before and after IV allopurinol (150 mg/m2 over one
hour) (n = 8) or placebo (n = 10). All patients received intracoronary infusions
of an endothelium-independent dilator ladenosine [2.2 mg/min] or nitroglyc-
erin [40 !Lg]). A blinded analysis of arterial responses was performed using
automated quantitative angiography. In Placebo patients, serial responses to
ACH were identical (-19 ± 4%1-18 ± 5%, P = ns) (expressed as percent
change pre/post placebo). However, in Allopurinol patients, ACH responses
were dramatically improved after IV allopurinol (-20:l: 5%1-10 ± 5%, P =
0.01). Allopurinol did not affect resting coronary dimensions. Endothelium-
independent responses were similar in both groups. Thus, XO inhibition im-
proves coronary artery EMR in patients with coronary risk factors and early
atherosclerosis. This suggests that XO-generated superoxide anion, via de-
struction of nitric oxide, contributes to the impairment of EMR in coronary
atherosclerosis.
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Nitroglycerin (NTG) is metabolized to nitric oxide (NO) in vascular smooth
muscle cells. It has been suggested that prolonged exposure to NO results
in reduced vascular sensitivity to NO and/or down regulation of NO synthe-
sis. Whether such changes contribute to the in vivo development of nitrate
tolerance is currently not clear, This study investigates NO-mediated vasodi-
lation in conscious rats before and after development of nitrate tolerance.
Tolerance was induced by a 72 hours Lv. infusion of NTG and confirmed by
a 68% reduction in the response to NTG (from 25 ± 3 to 8 ± 1 mmHg, p <
0.05, n = 7). The hypotensive effects of acetylcholine (ACh, endothelium de-
pendent NO release, 10 !Lglkg), and sodium nitroprusside (SNP, releases NO
spontaneously, 20 !Lglkg), were examined before and after infusion of NTG.
Nitrate tolerance was associated with a attenuated hypotensive response to
ACh (before 24 ± 3; after 17 ± 2 mmHg, n = 7, P < 0.05). Similarly, the re-
sponse to SNP was reduced from 32 ± 1 to 26 ± 3 mmHg, n = 7, P < 0.05).
Infusion of placebo (NTG solvens, n = 6) for 72 hours did not affect the re-
sponse to ACh and SNP (p > 0.05). An effect of NTG treatment on endoge-
nous NO regulation was further substantiated by the finding of a 62% reduc-
tion in the hypertensive response to the NO synthase inhibitor, L-NAME (n
= 6), after induction of nitrate tolerance (from 29 ± 6 to 11 ± 1 mmHg, p <
0.05). The results suggest that prolonged infusion of NTG attenuates the va-
sodilator effects of NO, whether it is derived from the endothelium (ACh) or
from exogenous sources (SNP) and that reduced vascular sensitivity to NO-
dependent vasodilation may contribute to the development of nitrate toler-
ance in vivo.
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Increases in circulating atrial natriuretic peptide (ANP) and norepinephrine
(NE) occur during the evolution of heart failure. While NE may augment ANP
synthesis, a modulating action upon the biological actions of ANP is unclear.
In vitro, the beta-adrenergic agonist IPA) isoproterenol (ISO) down-regulates
the AN Pclearance receptor which indirectly augments the biologically active
ANP receptor. In vivo, the pA antagonist propranolol attenuates natriuretic
peptide mediated coronary vasodilatation. We therefore hypothesized that,
in vivo, ISO would potentiate subthreshold coronary vasodilating actions of
ANP Five anesthetized dogs were instrumented to measure left circumflex
(LCx) coronary blood flow ICBF). Intracoronary (IC) ANP (100 nglbolus) was
administered in the LCx before and after the IC-ISO (1 mg over 15 min). Acetyl-
choline (ACh 1 nglkg) and sodium nitroprusside (SNP 100 nglkg) were admin-
Potentiation of Atrial Natriuretic Peptide
Mediated Coronary Vasodilatation by Beta
Adrenergic Stimulation
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Endogenous Nitric Oxide Production
Contributes to Increases in Coronary Blood
Flow During Exercise
Coronary Denervation Attenuates Vasospasm
Induced by Pericoronary Application of
Methacholine in Pigs
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d'Hebron, Barcelona, Spain
Autonomic innervation of the coronary arteries is thought to intervene in the
genesis of coronary vasospasm, We assessed the potential effect of selec-
tive coronary denervation in the inhibition of vasospasm. Chronic sympa-
thetic and parasympathetic denervation was provoked by topical applica-
tion of phenol to the proximal LAD in 20 pigs through a lateral thoracotomy.
Two weeks later, we performed an midsternal thoracotomy. Heart rate, aor-
tic and ventricular (LV) pressure, LV dP/dt, coronary blood flow (CBF) at the
LAD, and 32-channel epicardial ST segment mapping were monitored during
every MCH application. Phenol-induced coronary adrenergic and cholinergic
denervation was confirmed by histofluorescence and cholinesterase stain-
ing, Isolated LAD rings of 5 phenol-denervated pigs were studied to confirm
smooth muscle integrity, Application of MCH to control pigs (n = 10) induced
an statistically significant fall in CBF (75 ± 19%) accompanied by electrical
and mechanical signs of ischemia: mean ST segment elevation on the epi-
cardial electrograms of 9,7 ± 4.7 mV, a drop in systolic LV pressure (-20 ±
8.4 mmHg) and a decrease in LV dP/dt (-404 ± 203 mmHg/s). There were
no changes in heart rate. The parameters returned to normal values after 5 to
8 min. As compared to controls, phenol treated pigs showed a significant at-
tenuation ofthe fall in CBF (25 ± 17%), lesser ST segment elevation (2.4 ± 2.1
mV), a lower drop in LV pressure (-8 ± 2.3 mmHg), and a smaller decrease
in LV dP/dt (-167 ± 104 mmHg/s). Coronary angiography performed in 6 ad-
ditional pigs evidenced that the coronary spasm occurred at the site of MCH
exposure. Isolated LAD rings of phenol treated pigs constrict after incubation
with endothelin-l indicating preserved vascular smooth muscle function. In 5
control pigs, a second application of MCH after muscarinic receptor blockade
with atropine (0.4 mg/kg Lv.) resulted in complete abolition of the vasospasm
confirming that vasospasm was mediated by the muscarinic receptor stim-
ulation. In conclusion, pericoronary autonomic denervation protects against
coronary constriction induced by direct muscarinic receptor stimulation with
methacholine in situ the pig heart.
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Inhibition of nitric oxide (NO) production does not impair the normal ability to
increase coronary blood flow (CBF) during exercise (Ex). We previously ob-
served that KATP channel blockade decreased CBF at rest and during exer-
cise, but KATP channel blockade either alone or in combination with adeno-
sine blockade did not prevent exercise-induced increases of CBF. This study
was performed to determine whether exercise-induced increases in CBF af-
ter KATP channel blockade and adenosine receptor blockade are dependent
upon endothelial NO production. Ten dogs with a Doppler flow probe and
microcatheter in the left anterior descending coronary artery were studied
at rest and during 2 levels of treadmill Ex. Studies were performed during
control conditions (CON) and then with the combination of glibenclamide
(G) (50 !L9/kg/min intracoronary) to produce KATP channel blockade and 8-phenyltheophylline (PTI (5 mglkg iv) as an adenosine receptor blocker. Finally,
measurements were repeated when NO production was inhibited by adding
N-nitro-L-arginine (L) (1.5 mg/kg intracoronary). Data are mean ± SE.
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